HALOZYME THERAPEUTICS SHARES UP 2% AFTER COURT WIN AGAINST MERCK TO BLOCK SUBCUTANEOUS KEYTRUDA IN SELECT MARKETS

Reuters · 4d ago

Please log in to view news